Japan yesterday approved the resumption of nuclear power operations at two reactors despite mass public opposition, the first to come back on line after they were all shut down following last year’s Fukushima Dai-ichi nuclear crisis.
Japanese Prime Minister Yoshihiko Noda, his popularity ratings sagging, had backed the restarts for some time. He announced the government’s decision at a meeting with key ministers, giving the go-ahead to two reactors operated by Kansai Electric Power Co at Ohi in western Japan.
The decision could open the door to more restarts among Japan’s 50 nuclear power reactors.
“There is no such thing as a perfect score when it comes to disaster prevention steps,” Japanese Trade Minister Yukio Edano told a news -conference after the announcement.
“But, based on what we learned from the Fukushima accident, those measures that need to be taken urgently have been addressed, and the level of safety has been considerably enhanced [at the Ohi plant],” he said.
Edano, who holds the energy portfolio, said the government policy to reduce Japan’s dependence on nuclear energy in the medium to long-term was unchanged despite the decision.
The decision is a victory for Japan’s still-powerful nuclear industry and reflects Noda’s concerns about damage to the economy if atomic energy is abandoned following the world’s worst nuclear disaster since Chernobyl.
The push to restart the two Ohi reactors, before a potential summer power crunch, also underscores the premier’s eagerness to win backing from businesses worried about high electricity costs that could push factories offshore. Kansai electric says it will take six weeks to get both reactors running fully.
However, the decision risks a backlash from a public deeply concerned about nuclear safety. As many as 10,000 demonstrators gathered outside Noda’s office on Friday night amid a heavy police presence to denounce the restarts, urging the premier to step down and shouting: “Lives matter more than the economy.”
Nuclear power supplied almost 30 percent of electricity needs before the disaster in March last year, which triggered meltdowns at the Fukushima Dai-ichi plant, spewing radiation and forcing mass evacuations.
All 50 reactors were shut down for maintenance or safety checks in the months since the accident. The government had placed a priority on gaining the approval of local communities for the Ohi restarts to avert July-August power shortages.
Critics say the government was too hasty in signing off on the restarts, especially given delays in setting up a new, more independent nuclear regulatory agency.
Public trust in regulators was damaged by evidence that cozy ties with utilities were a key reason Fukushima operator Tokyo Electric Power Co was unprepared for the tsunami, and subsequent signs that relations remain far too snug.
Parliament’s lower house on Friday approved legislation to create a new atomic regulator, but getting it up and running will take months. That could force the government to go slower on restarts, though some politicians are keen to forge ahead.
BREAKING RECORDS: Kuo Hsing-chun’s snatch, clean and jerk, and combined lifts were all Olympic records, although well off her combined world record Taiwanese weightlifter Kuo Hsing-chun (郭婞淳) yesterday completed her elusive quest for Olympic gold, clinching Taiwan’s first win at the Tokyo Games as she set Olympic records in the women’s under-59kg weight class. Kuo, who has not lost a major competition in her weight class since the 2016 Olympics in Rio de Janeiro, where she was hampered by injury and finished third, finally chased down the gold medal that had long remained just out of her grasp. The 27-year-old finished with a combined lift of 236kg — 103kg in the snatch and 133kg in the clean and jerk — 21kg more
NEXT ROUND: About 1.44 million people who have registered online to receive the AstraZeneca vaccine are to get text messages today to book a vaccine appointment Strict border control measures, including a ban on foreign nationals entering or transiting through Taiwan, are to continue, the Central Epidemic Command Center (CECC) said yesterday, as it reported 10 locally transmitted COVID-19 infections and no deaths. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said five of the cases tested positive during isolation or upon ending it. The sources of infection of eight cases have been identified, one remains unclear and one is under investigation, he said, adding that 87.8 percent of the people infected with COVID-19 since May 11 have been released from isolation. Chen said an
NO ‘ONE CHINA’ LIE: The appropriations act passed the US House of Representatives with a vote of 217-212, but still needs Senate approval and the president’s signature The US House of Representatives on Wednesday passed a foreign assistance spending bill with an amendment forbidding that funds be used to create, procure or display maps depicting Taiwan as part of the People’s Republic of China. The amendment was introduced by five Republican representatives — Tom Tiffany, Steve Chabot, Scott Perry, Kat Cammack and Mike Gallagher — and passed unanimously in a bundle with a dozen other amendments. “This is a common sense measure,” Tiffany said, speaking on the House floor on Wednesday. “As we all know, Taiwan has never been part of communist China. The Taiwanese people elect their
THE HOME TEAM: DPP Legislator Kao Chia-yu said she canceled her booking for an AstraZeneca shot as soon as she heard that the Medigen vaccine was an option President Tsai Ing-wen (蔡英文) yesterday said that she would get inoculated with the COVID-19 vaccine manufactured by Taiwan-based Medigen Vaccine Biologics Corp (高端疫苗). Tsai wrote on Facebook that she had registered for her first vaccine dose using the national online COVID-19 vaccination booking system, which allows people to indicate their preferred vaccine brand and to make an appointment when the shot becomes available. Tsai said that she opted for the Medigen vaccine — one of three now available on the system, along with the AstraZeneca and Moderna vaccines — even though Medigen has yet to deliver any doses or provide a